In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 5-6, 2008, Pages 625-629

  Ajith, T A ^a   Riji, T ^a   Anu, V ^a  

^a AMALA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anti oxidant; Hypolipidaemic; Lipid peroxidation; Statin

Indexed keywords

ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT; DNA; DNA FRAGMENT; FERRIC ION; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLASMID DNA; RIBOFLAVIN; ROSUVASTATIN; SUPEROXIDE;

AGING; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; BODY FAT; BRAIN HOMOGENATE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FAT INTAKE; FENTON REACTION; FERRIC REDUCING ANTI OXIDANT POWER; ILLUMINATION; IN VITRO STUDY; LIPID PEROXIDATION; LIVER HOMOGENATE; LIVER MITOCHONDRION; NONHUMAN; NUCLEIC ACID STRUCTURE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN STRUCTURE; RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID PEROXIDATION; MITOCHONDRIA, LIVER; PYRIMIDINES; RATS; SULFONAMIDES;

EID: 41749108172     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04853.x     Document Type: Article

References (32)

1. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991 3 : 1 7.
2. Cooke MS, Evans MD, Dizdarglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation and disease. FASEB J. 2003 17 : 1195 214.
3. Blauw GJ, Lagaay AM, Westendorp RG. Statins for prevention of stroke. Lancet 1998 352 : 144.
4. Endres M, Laufs U, Huang Z et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 1998 95 : 8880 5.
5. Farnier M, Davignon J. Current and future treatment of hyperlipidemia: The role of statins. Am. J. Cardiol. 1998 82 (Suppl J3 10.
6. Crisby M, Carlson LA, Winblad B. Statins in the prevention and treatment of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2002 16 : 131 6.
7. Waldman A, Kritharides L. The pleiotropic effects of HMG-CoA reductase inhibitors: Their role in osteoporosis and dementia. Drugs 2003 63 : 139 52.
8. Chan KKW, Oza AM, Siu LL. The statins as anticancer agents. Clin. Cancer Res. 2003 9 : 10 19.
9. Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins. An update. Fundam. Clin. Pharmacol. 2005 19 : 117 25.
10. Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto W. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am. J. Cardiol. 2005 95 : 360 6.
11. Miersch S, Sliskovic I, Raturi A et al. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes. Free Radic. Biol. Med. 2007 42 : 270 9.
12. Resch U, Tatzber F, Budinsky A et al. Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy. Br. J. Clin. Pharmacol. 2006 61 : 262 74.
13. Hsu M, Muchova L, Morioka I et al. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem. Biophys. Res. Commun. 2006 343 : 738 44.
14. Verreth W, De Keyzer D, Davey PC, Mutus B. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice. Br. J. Pharmacol. 2007 15 : 347 55.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979 95 : 351 8.
16. Ajith TA, Subin JP, Jacob J, Sanjay PS, Babitha NV. Antimutagenic and antioxidant activities of the non-steroidal anti-inflammatory drug celecoxib. Clin. Exp. Physiol. Pharmacol. 2005 32 : 888 93.
17. Ajith TA, Divya KR. An in vitro comparative study on the antioxidant activity and determination of antibacterial potential of atorvastatin and simvastatin. Pharmaceut. Biol. 2007 45 : 1 5.
18. Ajith TA, Harikumar KB, Thasna H, Sabu MC, Babitha NV. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Clin. Chim. Acta 2006 366 : 322 8.
19. Halliwell B, Gutteridge JMC. Protection against radicals in biological systems: The superoxide theory of oxygen toxicity. In : Halliwell B, Gutteridge JMC (eds). Free Radical in Biology and Medicine. Clarendon Press, New York. 1985 67 138.
20. Wei YH. Oxidative stress and mitochondrial DNA mutations in human aging. Proc. Soc. Exp. Biol. Med. 1998 217 : 53 63.
21. Richter C, Gogvadze V, Laffranchi R et al. Oxidants in mitochondria: From physiology to disease. Biochem. Biophys. Acta 1995 1271 : 67 74.
22. Davis KJ, Packer L, Brooks GA. Biochemical adaptation of mitochondria, muscle, and whole-animal respiration to endurance training. Arch. Biochem. Biophys. 1981 209 : 539 54.
23. Buckman TD, Sitphin MS, Mitrovic B. Oxidative stress in a clonal cell line of neuronal origin: Effects of antioxidant enzyme modulation. J. Neurochem. 1993 60 : 2046 58.
24. Ishikawa Y, Satoh T, Enokido Y, Nishio C, Ikeuchi T, Hatanka H. Generation of reactive oxygen species, release of l-glutamate and activation of caspasees are required for oxygen induced apoptosis of embryonic hippocampal neurons in culture. Brain Res. 1999 824 : 71 80.
25. Xing H, Sun S, Mei Y, Herman D. The protective effect of rosuvastatin on ischemic brain injury and its mechanism. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2006 26 : 667 9.
26. Suzumura K, Yasuhara M, Tanaka K, Nishio C, Ikeuchi T, Hatanka H. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor. Chem. Pharm. Bull. 1999 47 : 1010 12.
27. Franzoni F, Quinones-Galvan A, Regoli F, Ferrannini E, Galetta F. A comparative study of the in vitro antioxidant activity of statins. Int. J. Cardiol. 2003 90 : 317 21.
28. Henle ES, Linn S. Formation, prevention and repair of DNA damage by iron/hydrogen peroxide. J. Biol. Chem. 1997 272 : 19 095 8.
29. Halliwell R, Aruoma OI. DNA damage by oxygen-derived species. FEBS Lett. 1991 281 : 9 19.
30. Imlay JA, Chin SM, Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1998 240 : 640 2.
31. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J. 1996 313 : 17 29.
32. Feron VJ, Til HP, De V et al. Aldehyde occurrence, carcinogenic potential mechanism of action and risk assessment. Mutat. Res. 1991 259 : 363 5.